BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36351890)

  • 1. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway.
    Chen S; Cai K; Zheng D; Liu Y; Li L; He Z; Sun C; Yu C
    Cell Death Dis; 2022 Nov; 13(11):945. PubMed ID: 36351890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA 00976 promotes pancreatic cancer progression through OTUD7B by sponging miR-137 involving EGFR/MAPK pathway.
    Lei S; He Z; Chen T; Guo X; Zeng Z; Shen Y; Jiang J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):470. PubMed ID: 31747939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sprouting angiogenesis is regulated by shedding of the C-type lectin family 14, member A (CLEC14A) ectodomain, catalyzed by rhomboid-like 2 protein (RHBDL2).
    Noy PJ; Swain RK; Khan K; Lodhia P; Bicknell R
    FASEB J; 2016 Jun; 30(6):2311-23. PubMed ID: 26939791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhomboid-Like-2 Intramembrane Protease Mediates Metalloprotease-Independent Regulation of Cadherins.
    Battistini C; Rehman M; Avolio M; Arduin A; Valdembri D; Serini G; Tamagnone L
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31783481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RHBDL2 is a critical membrane protease for anoikis resistance in human malignant epithelial cells.
    Cheng TL; Lai CH; Jiang SJ; Hung JH; Liu SK; Chang BI; Shi GY; Wu HL
    ScientificWorldJournal; 2014; 2014():902987. PubMed ID: 24977233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OTUD7B deubiquitinates and stabilizes YAP1 to upregulate NUAK2 expression, thus accelerating gastric cancer procession.
    Guo Z; Guo L
    Dig Liver Dis; 2024 Feb; 56(2):352-362. PubMed ID: 37429790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A microprotein N1DARP encoded by LINC00261 promotes Notch1 intracellular domain (N1ICD) degradation via disrupting USP10-N1ICD interaction to inhibit chemoresistance in Notch1-hyperactivated pancreatic cancer.
    Zhai S; Lin J; Ji Y; Zhang R; Zhang Z; Cao Y; Liu Y; Tang X; Liu J; Liu P; Lin J; Li F; Li H; Shi Y; Fu D; Deng X; Shen B
    Cell Discov; 2023 Sep; 9(1):95. PubMed ID: 37714834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MICAL1 facilitates pancreatic cancer proliferation, migration, and invasion by activating WNT/β-catenin pathway.
    Cai K; Deng L; Zheng D; Li L; He Z; Yu C
    J Transl Med; 2022 Nov; 20(1):528. PubMed ID: 36371204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway.
    Li ZX; Wu G; Jiang WJ; Li J; Wang YY; Ju XM; Yin YT
    Cell Cycle; 2020 Jan; 19(2):233-245. PubMed ID: 31876226
    [No Abstract]   [Full Text] [Related]  

  • 10. Functions of rhomboid family protease RHBDL2 and thrombomodulin in wound healing.
    Cheng TL; Wu YT; Lin HY; Hsu FC; Liu SK; Chang BI; Chen WS; Lai CH; Shi GY; Wu HL
    J Invest Dermatol; 2011 Dec; 131(12):2486-94. PubMed ID: 21833011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-11 (IL-11) receptor cleavage by the rhomboid protease RHBDL2 induces IL-11 trans-signaling.
    Koch L; Kespohl B; Agthe M; Schumertl T; Düsterhöft S; Lemberg MK; Lokau J; Garbers C
    FASEB J; 2021 Mar; 35(3):e21380. PubMed ID: 33566379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2.
    Pascall JC; Brown KD
    Biochem Biophys Res Commun; 2004 Apr; 317(1):244-52. PubMed ID: 15047175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OTUD7B suppresses Smac mimetic-induced lung cancer cell invasion and migration via deubiquitinating TRAF3.
    Zhang B; Yang C; Wang R; Wu J; Zhang Y; Liu D; Sun X; Li X; Ren H; Qin S
    J Exp Clin Cancer Res; 2020 Nov; 39(1):244. PubMed ID: 33198776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRIM59 predicts poor prognosis and promotes pancreatic cancer progression via the PI3K/AKT/mTOR-glycolysis signaling axis.
    Li R; Weng L; Liu B; Zhu L; Zhang X; Tian G; Hu L; Li Q; Jiang S; Shang M
    J Cell Biochem; 2020 Feb; 121(2):1986-1997. PubMed ID: 31693252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-specific protease 4 predicts an unfavorable prognosis and promotes malignant behaviors in vitro in pancreatic cancer.
    Wang Y; Zhou L; Lu J; Jiang B; Liu C; Liang Z; Zhou W; Guo J
    Exp Cell Res; 2020 Nov; 396(2):112317. PubMed ID: 33038351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway.
    Meng LD; Shi GD; Ge WL; Huang XM; Chen Q; Yuan H; Wu PF; Lu YC; Shen P; Zhang YH; Cao SJ; Miao Y; Tu M; Jiang KR
    Cancer Lett; 2020 Dec; 494():107-120. PubMed ID: 32814086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation Negatively Regulates Angiogenesis by Targeting Endothelial NOTCH Signaling.
    Zhu X; Ding S; Qiu C; Shi Y; Song L; Wang Y; Wang Y; Li J; Wang Y; Sun Y; Qin L; Chen J; Simons M; Min W; Yu L
    Circ Res; 2017 Sep; 121(6):636-649. PubMed ID: 28760777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OTUD7B stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
    Tang J; Wu Z; Tian Z; Chen W; Wu G
    Cell Death Dis; 2021 May; 12(6):534. PubMed ID: 34035221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
    Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.